Skip to main content
. Author manuscript; available in PMC: 2025 Aug 1.
Published in final edited form as: J Clin Pharmacol. 2024 Mar 28;64(8):963–974. doi: 10.1002/jcph.2434

Table 3.

Population PK Parameter Values Reported by Models Chosen for Analysis

Variable Median (range) or N (%)
Potts15 James16 Morse17 Pérez-Guillé18 Wiczling19

CL (L/h/70kg) 42.1 27.3 53.8 20.8 41.6
V1 (L/70kg) 56.3 161 25.2 21.9 52
Q,Q2 (L/h/70kg) 78.3 26.0 100.8, 37.2 75.8 56.8
V2,V3 (L/70kg) 69 7903 34.4, 65.4 81.2 70.4

IIV (%CV)a
 CL, Q, Q2 30.9, 37.0 103, 82 35.8, 63.2, 89.7b 27.5, 25.3 30.9, 37
 V1, V2, V3 61.3, 47.0 138, 624 103.9, 41.8, 61.6b 20.2, 21.8 61.3, 47

Residual errora
 Additive 0 Fixed 0 Fixed 0.004 (μg/mL) 0 Fixed 0 Fixedc
 Proportional (%CV) 16.2 50.5 19 14.2 0 Fixedc
Covariates
 Covariate Age on CL
Surgery on CLd
PMA on CL Age on CL
Fat mass on V
NA Age on CL
 Effect size TM50=44.5
Hill = 2.56
Finf = 0.73
TM50=41.9
Hill = 7.04
TM50=52.4
Hill = 1 Fixed
Ffat = 0.293
NA TM50=44.5
Hill = 2.45
a

All IIV and Residual Error values (as %CV unless otherwise noted) shown as reported in each publication.

b

Reported as population parameter variability percent or PPV%.

c

Model utilized an exponential error model where EPS = 0.1.

d

Where Finf represents the proportion of pre-surgery clearance that is observed for dexmedetomidine infusions after surgery within the study populations.

Cl, clearance; CV, coefficient of variation; EPS, epsilon or the variance of the normally distributed residual error values; Ffat, fractional influence of fat mass on volume of distribution compared to lean body weight; Finf, proportional clearance observed within 24 hours after surgery; Hill, exponent describing the slope of the maturation curve; IIV, Inter-individual variability; PPV%, population parameter variability percent; PMA, Post-menstrual age; Q, inter-compartmental clearance; TM50, age in weeks at 50% of adult clearance; V, Volume of distribution.